{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:13:29Z","timestamp":1778339609213,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.semnephrol.2004.06.004","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T13:22:07Z","timestamp":1222003327000},"page":"495-501","source":"Crossref","is-referenced-by-count":24,"title":["Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Daniela","family":"Molino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natale G.","family":"De Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahrokh","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"De Lucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2004.06.004_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.2830070203","article-title":"Bleeding time in uremia","volume":"7","author":"Steiner","year":"1979","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib2","first-page":"82","article-title":"Coagulation abnormalities in uremia","volume":"5","author":"Livio","year":"1985","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(88)92019-3","article-title":"Bleeding in renal failure","volume":"1","author":"Remuzzi","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V94.8.2569.420k13_2569_2574","article-title":"Uremic bleeding","volume":"94","author":"Noris","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib5","first-page":"40","article-title":"Haemodialysis and platelet activation","volume":"2","author":"Deguchi","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ki.1997.117","article-title":"Increased reticulated platelets in dialysis patients","volume":"51","author":"Himmelfarb","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.2.6036.612","article-title":"Bleeding in renal failure","volume":"2","author":"Kazatchkine","year":"1976","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0272-6386(12)80136-3","article-title":"Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease","volume":"23","author":"Vaziri","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V781169","article-title":"Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients","volume":"7","author":"De Marchi","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9343(85)90051-8","article-title":"Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis","volume":"79","author":"Di Mimmo","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.3.5821.281","article-title":"Haematoma of rectus abdominis associated with dialysis","volume":"3","author":"De Santo","year":"1972","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1681\/ASN.V1261255","article-title":"Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients","volume":"12","author":"Segarra","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000045504","article-title":"Hypercoagulopathy in a hemodialysis patient","volume":"83","author":"Baskin","year":"1999","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib14","first-page":"428","article-title":"IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis","volume":"56","author":"Adler","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","article-title":"Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis","volume":"26","author":"Prakash","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","article-title":"Are antiphospholipid antibodies clinically relevant in dialysis patients","volume":"14","author":"Chew","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000189101","article-title":"Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis","volume":"73","author":"Ishii","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib18","first-page":"1008","article-title":"Antiphospholipid antibodies and the coagulation cascade","volume":"47","author":"Angles-Cano","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00365510310000989","article-title":"Haemostatic complications in haemodialysis patients","volume":"63","author":"Yu","year":"2003","journal-title":"Scand J Clin Lab"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/039139888400700606","article-title":"Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis","volume":"7","author":"Vaziri","year":"1984","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib21","first-page":"235","article-title":"Subclavian vein thrombosis","volume":"26","author":"Vanherweghem","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib22","first-page":"28","article-title":"Hypercoagulability","volume":"9","author":"Kauffman","year":"1979","journal-title":"Proc Clin Dial Transplant Forum"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF03344054","article-title":"Coagulation and fibrinolysis abnormalities in obesity","volume":"25","author":"De Pergola","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib24","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1053\/ajkd.2001.29280","article-title":"Oxidative stress and inflammation in hemodialysis patients","volume":"38","author":"Spittle","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2004.06.004_bib25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/ndt\/16.7.1442","article-title":"Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients","volume":"16","author":"Borwski","year":"2001","journal-title":"Nephrol Dial Transplant"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929504000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929504000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:11:12Z","timestamp":1631833872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929504000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0270929504000877"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2004.06.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}